The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
Overview of the Program
CHAI has been supporting the Government of Nigeria to scale-up access to antimalarials and malaria rapid diagnostics in Nigeria since 2016. CHAI’s strategic approach for malaria in Nigeria employs a multi-stakeholder coalition for scale-up. This coalition consists of committed public, private, and non-governmental organizations implementing a diverse set of interventions.
Artemisinin-based combination therapy (ACT) was introduced as the first-line antimalarial treatment in the mid-2000s, replacing older drugs due to widespread resistance. However, the high cost of ACTs initially limited access. Subsidies in the private sector significantly reduced retail prices by up to tenfold, improving affordability and availability, especially for vulnerable populations. This price drop, however, created a trade-off: while access improved, inappropriate use among patients without malaria also increased. An independent evaluation of the Affordable Medicines Facility-malaria (AMFm) pilot program, across eight countries, showed that ACT availability and market share rose substantially in most settings. Yet, many of the $216 million worth of subsidized ACTs were likely consumed by individuals who did not have malaria.
In 2023–2024, CHAI, with funding from GiveWell, implemented a randomized controlled trial to assess the impact of providing low-cost malaria rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs) on improving the management of febrile illnesses in private medicine retailers (PMRs). The primary objective was to increase the proportion of patients with confirmed malaria who receive appropriate treatment with ACTs, particularly in communities with limited access to diagnosis and treatment. Following a successful pilot where the intervention led to a 63% increase in treatment access and a 60% increase in diagnostic uptake, CHAI is now scaling up the intervention in Kaduna and Katsina States.
The Private Retailers for Improved Malaria Excellence (PRIME) project aims to increase access to affordable malaria diagnostics and treatment among populations with limited access to formal healthcare. Under this initiative, CHAI will support the implementation of malaria case management services across 2,000 private medicine retailers (PMRs) in underserved communities in Kaduna and Katsina States. These PMRs will be equipped with subsidized artemisinin-based combination therapies (ACTs) and malaria rapid diagnostic tests (RDTs) to improve the availability and appropriate use of these life-saving commodities. In addition to service delivery, the project will include a strong monitoring and research component; Routine data will be collected directly from PMRs to assess uptake and usage trends. While supplementary exit interviews will be conducted with clients to evaluate the effectiveness of the intervention in improving access, testing rates, and treatment adherence.
Overview of the Position
CHAI is seeking TWO Analysts, to support the implementation of the PRIME project in Kaduna State and in Katsina State. The Analysts will play a key role in overseeing and driving effective execution of program activities at the state level, working closely with government stakeholders, private sector actors, and implementing partners. The roles will include coordinating planning and implementation processes, facilitating stakeholder engagement, monitoring progress, and supporting data-driven decision-making across project sites.
The ideal candidates will be highly motivated and strategic thinkers with strong program management skills, experience working with government systems, and a demonstrated ability to lead complex tasks in fast-paced environments. Additionally, the successful candidates are expected to demonstrate the following core CHAI values: resourcefulness, responsibility, patience, tenacity, humility, frugality, independence, and work ethics.
One Analyst will be based in Kaduna State and the other Analyst will be based out of Katsina State. Please make sure to specify your base location preference in the application.
Advantages:
#jobreference1 #region4
Software Powered by iCIMS
www.icims.com